Form 4: CapsoVision Grants Options to Sr. VP of Finance

Sentiment:

Insider Transaction Report


CapsoVision, Inc. granted 165,000 stock options to Senior VP of Finance David Michael Garcia with an exercise price of $4.78, vesting over four years.

Summary

  • David Michael Garcia, Senior VP of Finance at CapsoVision, Inc. (CV), was granted 165,000 stock options.
  • The options have an exercise price of $4.78 per share.
  • The transaction date for the grant was November 3, 2025.
  • The options vest as to 25% of the shares on November 3, 2026, and the remaining 75% in 36 equal monthly installments thereafter through November 3, 2029.
  • Vesting is contingent upon continued service to the Issuer.
  • The options expire on November 3, 2035.
  • Following this transaction, David Michael Garcia beneficially owns 165,000 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of stock options to a senior executive is generally viewed positively as it aligns management's long-term interests with those of shareholders, incentivizing performance and retention. This is a standard compensation practice.

Positives

  • Granting stock options to a senior executive like the Sr. VP of Finance aligns management's long-term interests with those of shareholders.
  • The vesting schedule, extending over four years, incentivizes sustained performance and retention of key personnel.

Future Outlook

NA

Industry Context

Granting stock options to senior executives is a common practice across various industries to attract, retain, and motivate key talent, aligning their financial incentives with the company's long-term performance and shareholder value creation.

Comparison to Industry Standards

  • The grant of stock options with a multi-year vesting schedule is a standard executive compensation practice, comparable to programs at companies like Apple Inc. or Microsoft Corp., which use similar equity-based incentives to retain top talent and align executive interests with long-term shareholder value.
  • The exercise price of $4.78, likely the market price on the grant date, is typical for at-the-money options, a common structure in executive compensation plans.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PracticeThe grant of stock options reflects standard corporate governance practices regarding executive compensation, designed to incentivize performance and align executive interests with shareholder value.11/03/2025Enhances alignment between executive incentives and long-term shareholder value creation.

Stakeholder Impact

  • Shareholders: Potential for increased shareholder value if the options incentivize the executive to drive company performance, leading to stock price appreciation.
  • Employees: May signal stability in the executive team and a commitment to long-term growth.
  • Management: Provides a significant long-term incentive and a direct stake in the company's success.

Next Steps

  • David Michael Garcia's continued service to CapsoVision, Inc. to fulfill vesting conditions.
  • Potential exercise of options upon vesting and favorable stock price movement.

Key Dates

DateDescription
11/03/2025Date of stock option grant to David Michael Garcia.
11/03/2026First vesting date for 25% of the granted stock options.
11/03/2029Final vesting date for the remaining stock options.
11/03/2035Expiration date of the granted stock options.

Keywords

CapsoVision, CV, Stock Options, Executive Compensation, Insider Transaction, Form 4, David Garcia, Equity Grant, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.